Texas HB3265 prohibits discrimination against entities participating in the federal 340B drug discount program by health benefit plan issuers.

Texas HB3265 aims to prevent discriminatory practices by health benefit plan issuers, pharmacy benefit managers, third-party payors, and drug manufacturers against entities participating in the federal 340B drug discount program. The bill defines "340B drug" and "covered entity" and prohibits these entities from discriminating against covered entities, pharmacists, or pharmacies. It also bans lower reimbursement rates for 340B drugs, requirements for specific billing indicators, and differential terms for covered entities.

Texas HB3265 prohibits discrimination against entities participating in the federal 340B drug discount program by health benefit plan issuers.

Texas HB3265 aims to prevent discriminatory practices by health benefit plan issuers, pharmacy benefit managers, third-party payors, and drug manufacturers against entities participating in the federal 340B drug discount program. The bill defines "340B drug" and "covered entity" and prohibits these entities from discriminating against covered entities, pharmacists, or pharmacies. It also bans lower reimbursement rates for 340B drugs, requirements for specific billing indicators, and differential terms for covered entities.